IL128728A0 - Compositions for reducing host vs. graft reaction - Google Patents

Compositions for reducing host vs. graft reaction

Info

Publication number
IL128728A0
IL128728A0 IL12872897A IL12872897A IL128728A0 IL 128728 A0 IL128728 A0 IL 128728A0 IL 12872897 A IL12872897 A IL 12872897A IL 12872897 A IL12872897 A IL 12872897A IL 128728 A0 IL128728 A0 IL 128728A0
Authority
IL
Israel
Prior art keywords
hsp60
compositions
graft reaction
hvgr
severity
Prior art date
Application number
IL12872897A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL128728A0 publication Critical patent/IL128728A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12872897A 1996-08-30 1997-09-02 Compositions for reducing host vs. graft reaction IL128728A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/706,209 US5993803A (en) 1996-08-30 1996-08-30 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
PCT/US1997/015294 WO1998008536A2 (en) 1996-08-30 1997-09-02 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity

Publications (1)

Publication Number Publication Date
IL128728A0 true IL128728A0 (en) 2000-01-31

Family

ID=24836651

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12872897A IL128728A0 (en) 1996-08-30 1997-09-02 Compositions for reducing host vs. graft reaction
IL128728A IL128728A (en) 1996-08-30 1999-02-25 Compositions for reducing host vs. graft reaction

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL128728A IL128728A (en) 1996-08-30 1999-02-25 Compositions for reducing host vs. graft reaction

Country Status (11)

Country Link
US (1) US5993803A (de)
EP (1) EP0921810B1 (de)
JP (1) JP4256474B2 (de)
AT (1) ATE237344T1 (de)
AU (1) AU722576B2 (de)
CA (1) CA2263816C (de)
DE (1) DE69721007T2 (de)
DK (1) DK0921810T3 (de)
ES (1) ES2198594T3 (de)
IL (2) IL128728A0 (de)
WO (1) WO1998008536A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911772D0 (en) * 1999-05-21 1999-07-21 Semmelweis University Of Medic Diagnosis and treatment of atherosclerosis
JP2004501061A (ja) * 1999-12-15 2004-01-15 ペプトル・リミテツド 熱ショックタンパク質６０のフラグメントおよびアンタゴニスト
IL150113A0 (en) * 1999-12-15 2002-12-01 Peptor Ltd Fragments and antagonists of heat shock protein 60
US6812205B2 (en) * 2000-03-15 2004-11-02 The Brigham & Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
US7608683B2 (en) * 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
EP1335741A4 (de) * 2000-08-25 2005-10-26 Yeda Res & Dev METHODE ZUR PRÄVENTION VON AUTOIMMUNKRANKHEITEN MIT CpG-ENTHALTENDEN POLYNUCLEOTIDEN(04.03.02)
WO2002036611A2 (en) 2000-11-01 2002-05-10 The Regents Of The University Of California Immunomodulatory peptides derived from heat shock proteins and uses thereof
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) * 2002-02-19 2003-08-28 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
AU2003230181A1 (en) 2002-05-21 2003-12-02 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
WO2004090095A2 (en) * 2003-04-01 2004-10-21 University Of Southern California Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
EP1718158B1 (de) 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp-behandlung in verbindung mit einer antigenitätsarmen diät
CU23504A1 (es) 2004-09-24 2010-04-13 Ct Ingenieria Genetica Biotech Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas
EP1835933A4 (de) * 2005-01-04 2015-01-07 Yeda Res & Dev Hsp60, hsp60-peptide und t-zellen-impfstoffe zur immunmodulation
IN2014MN01887A (de) 2012-03-01 2015-07-10 Yeda Res & Dev
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
AU650065B2 (en) * 1990-09-06 1994-06-09 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Inhibitor of lymphocyte response and immune-related disease
IL114407A0 (en) * 1995-06-30 1995-10-31 Yeda Res & Dev Novel peptides and pharmaceutical compositions comprising them
IL114458A0 (en) * 1995-07-05 1995-11-27 Yeda Res & Dev Therapeutic preparations for treatment of T cell mediated diseases

Also Published As

Publication number Publication date
DK0921810T3 (da) 2003-07-28
IL128728A (en) 2006-09-05
CA2263816A1 (en) 1998-03-05
EP0921810A2 (de) 1999-06-16
EP0921810B1 (de) 2003-04-16
AU722576B2 (en) 2000-08-10
JP2001500488A (ja) 2001-01-16
ATE237344T1 (de) 2003-05-15
WO1998008536A2 (en) 1998-03-05
AU4242697A (en) 1998-03-19
DE69721007D1 (de) 2003-05-22
ES2198594T3 (es) 2004-02-01
DE69721007T2 (de) 2004-02-12
WO1998008536A3 (en) 1998-05-07
US5993803A (en) 1999-11-30
JP4256474B2 (ja) 2009-04-22
CA2263816C (en) 2008-12-30

Similar Documents

Publication Publication Date Title
ATE237344T1 (de) Senkung der heftigkeit einer host-versus-graft- reaktion durch unterdrueckung der hsp60 autoimmunitaet
GR3025918T3 (en) Immunosuppressive compounds
AU4721696A (en) An osteogenic device and a method for preparing the device
MY131553A (en) Lyophilized formulation of polyethylene oxide modified proteins with increased self-life
MY118995A (en) Oxygen absorption composition
EP1314405A3 (de) Implantat mit proliferationshemmender Substanz
GR3034187T3 (en) High concentration homogenized collagen compositions.
AU655915B2 (en) Cosmetic deodorants
HUT73317A (en) Poly-1-n-alkene-il-amines and motor fuel and lubricant compositions containing them
AU3506197A (en) Automatic voice/text translation of phone mail messages
GB2377122A (en) Voice mail interface
EP2295453A3 (de) Appetithemmendes Peptid, Zusammensetzung und Verwendung
AU1952597A (en) Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
WO1997011888A3 (de) Magazin für die fixierung von kleinteilen
EP0853068A3 (de) Mikroorganismus enthaltender Träger zur Verwendung in einem Wirbelschichtbett
NZ312327A (en) Controlling hemipteran insect pests with bacillus thuringiensis
IL135946A (en) Pesticide against plant-pathogenic microorganisms
GB2364616A (en) Electronic mail systems
AU3521495A (en) Implantable molded articles for the administration of active substances to plants
TW335356B (en) Permselective membranes and methods for their production
AU2002952492A0 (en) Chaperonin 10 immunosuppression
GB9007970D0 (en) Fuel oil compositions
AU1869601A (en) Pharmaceutical compositions comprising trimegestone
AU2002211256A1 (en) The use of lignins in thermoplastics
KR970064396A (ko) 스트레스 완화용 사료

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed